Logo image of COKE

COCA-COLA CONSOLIDATED INC (COKE) Stock Fundamental Analysis

NASDAQ:COKE - Nasdaq - US1910981026 - Common Stock - Currency: USD

1145.05  -6.21 (-0.54%)

Fundamental Rating

6

Overall COKE gets a fundamental rating of 6 out of 10. We evaluated COKE against 33 industry peers in the Beverages industry. Both the health and profitability get an excellent rating, making COKE a very profitable company, without any liquidiy or solvency issues. COKE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

COKE had positive earnings in the past year.
In the past year COKE had a positive cash flow from operations.
In the past 5 years COKE has always been profitable.
Each year in the past 5 years COKE had a positive operating cash flow.
COKE Yearly Net Income VS EBIT VS OCF VS FCFCOKE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.57%, COKE belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
Looking at the Return On Equity, with a value of 38.08%, COKE belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
COKE has a Return On Invested Capital of 16.00%. This is amongst the best in the industry. COKE outperforms 84.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for COKE is significantly above the industry average of 11.73%.
Industry RankSector Rank
ROA 10.57%
ROE 38.08%
ROIC 16%
ROA(3y)11.01%
ROA(5y)8.78%
ROE(3y)37.23%
ROE(5y)34.39%
ROIC(3y)17.65%
ROIC(5y)14.87%
COKE Yearly ROA, ROE, ROICCOKE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

COKE has a Profit Margin of 8.29%. This is comparable to the rest of the industry: COKE outperforms 57.58% of its industry peers.
In the last couple of years the Profit Margin of COKE has grown nicely.
The Operating Margin of COKE (12.99%) is comparable to the rest of the industry.
COKE's Operating Margin has improved in the last couple of years.
COKE has a Gross Margin of 39.77%. This is in the lower half of the industry: COKE underperforms 66.67% of its industry peers.
COKE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.99%
PM (TTM) 8.29%
GM 39.77%
OM growth 3Y19.1%
OM growth 5Y27.48%
PM growth 3Y39.11%
PM growth 5Y107.91%
GM growth 3Y4.34%
GM growth 5Y2.89%
COKE Yearly Profit, Operating, Gross MarginsCOKE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), COKE is creating value.
COKE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, COKE has less shares outstanding
The debt/assets ratio for COKE is higher compared to a year ago.
COKE Yearly Shares OutstandingCOKE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
COKE Yearly Total Debt VS Total AssetsCOKE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

COKE has an Altman-Z score of 4.04. This indicates that COKE is financially healthy and has little risk of bankruptcy at the moment.
COKE's Altman-Z score of 4.04 is fine compared to the rest of the industry. COKE outperforms 66.67% of its industry peers.
The Debt to FCF ratio of COKE is 3.67, which is a good value as it means it would take COKE, 3.67 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of COKE (3.67) is better than 81.82% of its industry peers.
COKE has a Debt/Equity ratio of 0.96. This is a neutral value indicating COKE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.96, COKE is not doing good in the industry: 60.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 3.67
Altman-Z 4.04
ROIC/WACC1.89
WACC8.48%
COKE Yearly LT Debt VS Equity VS FCFCOKE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

COKE has a Current Ratio of 2.03. This indicates that COKE is financially healthy and has no problem in meeting its short term obligations.
COKE's Current ratio of 2.03 is fine compared to the rest of the industry. COKE outperforms 66.67% of its industry peers.
A Quick Ratio of 1.76 indicates that COKE should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.76, COKE belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.03
Quick Ratio 1.76
COKE Yearly Current Assets VS Current LiabilitesCOKE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

COKE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.85%, which is quite impressive.
The Earnings Per Share has been growing by 50.15% on average over the past years. This is a very strong growth
COKE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.21%.
Measured over the past years, COKE shows a small growth in Revenue. The Revenue has been growing by 7.41% on average per year.
EPS 1Y (TTM)24.85%
EPS 3Y32.54%
EPS 5Y50.15%
EPS Q2Q%-33.21%
Revenue 1Y (TTM)3.21%
Revenue growth 3Y7.44%
Revenue growth 5Y7.41%
Sales Q2Q%-0.73%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COKE Yearly Revenue VS EstimatesCOKE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
COKE Yearly EPS VS EstimatesCOKE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2024 20 40 60

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.28, which indicates a correct valuation of COKE.
Based on the Price/Earnings ratio, COKE is valued cheaply inside the industry as 87.88% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 24.85. COKE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.28
Fwd PE N/A
COKE Price Earnings VS Forward Price EarningsCOKE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COKE is valued a bit cheaper than the industry average as 78.79% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COKE indicates a somewhat cheap valuation: COKE is cheaper than 75.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.44
EV/EBITDA 9.13
COKE Per share dataCOKE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The decent profitability rating of COKE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

COKE has a yearly dividend return of 0.85%, which is pretty low.
COKE's Dividend Yield is comparable with the industry average which is at 2.84.
With a Dividend Yield of 0.85, COKE pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 0.85%

5.2 History

The dividend of COKE is nicely growing with an annual growth rate of 83.00%!
COKE has been paying a dividend for at least 10 years, so it has a reliable track record.
COKE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)83%
Div Incr Years2
Div Non Decr Years34
COKE Yearly Dividends per shareCOKE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

5.3 Sustainability

COKE pays out 9.24% of its income as dividend. This is a sustainable payout ratio.
COKE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.24%
EPS Next 2YN/A
EPS Next 3YN/A
COKE Yearly Income VS Free CF VS DividendCOKE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
COKE Dividend Payout.COKE Dividend Payout, showing the Payout Ratio.COKE Dividend Payout.PayoutRetained Earnings

COCA-COLA CONSOLIDATED INC

NASDAQ:COKE (5/14/2025, 8:00:00 PM)

1145.05

-6.21 (-0.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)05-05 2025-05-05
Earnings (Next)07-29 2025-07-29
Inst Owners51.21%
Inst Owner Change-7.04%
Ins Owners4.39%
Ins Owner ChangeN/A
Market Cap9.98B
Analysts43.33
Price TargetN/A
Short Float %1.63%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield 0.85%
Yearly Dividend20.52
Dividend Growth(5Y)83%
DP9.24%
Div Incr Years2
Div Non Decr Years34
Ex-Date04-25 2025-04-25 (2.5)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.28
Fwd PE N/A
P/S 1.45
P/FCF 20.44
P/OCF 11.34
P/B 6.66
P/tB 18.42
EV/EBITDA 9.13
EPS(TTM)74.94
EY6.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)56.01
FCFY4.89%
OCF(TTM)100.95
OCFY8.82%
SpS789.92
BVpS171.95
TBVpS62.16
PEG (NY)N/A
PEG (5Y)0.3
Profitability
Industry RankSector Rank
ROA 10.57%
ROE 38.08%
ROCE 21.75%
ROIC 16%
ROICexc 25.11%
ROICexgc 39.56%
OM 12.99%
PM (TTM) 8.29%
GM 39.77%
FCFM 7.09%
ROA(3y)11.01%
ROA(5y)8.78%
ROE(3y)37.23%
ROE(5y)34.39%
ROIC(3y)17.65%
ROIC(5y)14.87%
ROICexc(3y)22.83%
ROICexc(5y)18.15%
ROICexgc(3y)37.03%
ROICexgc(5y)29.78%
ROCE(3y)23.99%
ROCE(5y)20.2%
ROICexcg growth 3Y24%
ROICexcg growth 5Y34.06%
ROICexc growth 3Y26.37%
ROICexc growth 5Y36.2%
OM growth 3Y19.1%
OM growth 5Y27.48%
PM growth 3Y39.11%
PM growth 5Y107.91%
GM growth 3Y4.34%
GM growth 5Y2.89%
F-Score5
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 3.67
Debt/EBITDA 1.31
Cap/Depr 195.52%
Cap/Sales 5.69%
Interest Coverage 250
Cash Conversion 80.38%
Profit Quality 85.54%
Current Ratio 2.03
Quick Ratio 1.76
Altman-Z 4.04
F-Score5
WACC8.48%
ROIC/WACC1.89
Cap/Depr(3y)180.96%
Cap/Depr(5y)149.39%
Cap/Sales(3y)4.98%
Cap/Sales(5y)4.39%
Profit Quality(3y)87.18%
Profit Quality(5y)123.89%
High Growth Momentum
Growth
EPS 1Y (TTM)24.85%
EPS 3Y32.54%
EPS 5Y50.15%
EPS Q2Q%-33.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.21%
Revenue growth 3Y7.44%
Revenue growth 5Y7.41%
Sales Q2Q%-0.73%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y6.04%
EBIT growth 3Y27.97%
EBIT growth 5Y36.93%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.37%
FCF growth 3Y12.27%
FCF growth 5Y34.6%
OCF growth 1Y44.71%
OCF growth 3Y18.87%
OCF growth 5Y24.72%